Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI-Powered app could offer personalized mental health support for stroke survivors

NCT ID NCT07691411

Symptom relief Sponsor: The Hong Kong Polytechnic University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This study tests whether a smartphone app that combines daily mood and activity surveys with artificial intelligence can help people recovering from a stroke manage depression, thinking difficulties, and daily functioning. Participants use the app for a period, answer brief surveys for one week, and receive personalized self-care suggestions generated by machine learning. The study aims to see if this approach is practical and acceptable for stroke survivors, and whether it improves mood, cognitive function, or daily activity.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Ecological Momentary Assessment based Self-management Program (smartphone app with AI-driven personalized messages)
What this could lead to
If successful, this approach could offer a practical, low-cost way for stroke survivors to get personalized support for mood and thinking difficulties at home.
What could go wrong
This is a small feasibility study with only 50 participants, so results may not apply to all stroke survivors. The app's benefits are unproven and may not improve outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * adults aged 18 years or older * having a confirmed diagnosis of stroke * having sufficient proficiency in Cantonese to understand and respond to the assessments and prompts * having a Hong Kong version of the Montreal Cognitive Assessment (HK-MoCA) score of 18 or higher * having a smartphone. Exclusion Criteria: * they have moderate to severe cognitive impairment (a HK-MoCA score of 17 or lower) * they have active psychiatric disorders other than depression (e.g., schizophrenia, bipolar disorder) * they have a terminal illness or prognosis that suggests a limited life expectancy * they have conditions that compromise their self-care ability (i.e., bedbound).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Post stroke are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depression stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Post stroke Stroke

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Queen Elizabeth Hospital

    RECRUITING

    Hong Kong, Hong Kong, 999077, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.